DKMS hires Jonathan Pearce as new CEO

Blood cancer charity DKMS has hired Jonathan Pearce as CEO of its UK operations to spearhead the organisation’s growth within the UK market.

Jonathan brings to DKMS over 15 years’ CEO experience of the UK charity sector, leading organisations such as Adoption UK and, more recently, Lymphoma Action from 2013 to 2018. Jonathan joins DKMS from the global Lymphoma Coalition Europe, where he was Regional Director.

DKMS is a charity dedicated to the fight against blood cancer by recruiting blood stem cell donors for people with blood cancers and disorders who are in need of a lifesaving stem cell transplant. Founded in Germany in 1991, the charity now operates in Germany, Poland, USA, UK, Chile and India – coming to the UK in 2013.

In its six years of operations in the UK, the charity has recruited over 500,000 potential blood stem cell donors and given over 800 people a second chance at life. However, with just 2% of the UK registered as potential lifesavers on the UK’s aligned stem cell registry, currently 4 in 10 people who need a blood stem cell transplant do not find their lifesaving donor match, and so the charity is on a mission to find a lifesaving blood stem cell donor for everyone who needs one.

Stephan Schumacher, Trustee of DKMS in the UK, said:

“We are delighted to welcome Jonathan to lead our UK operations. Jonathan has a wealth of knowledge and experience within the charity and health sectors, which will be invaluable to us as an organisation. This is an exciting time for DKMS in the UK and we look forward to growing our presence and providing more people with second chances at life under his leadership.”

DKMS hires Jonathan Pearce as new CEO
DKMS CEO Jonathan Pearce

Jonathan Pearce said:

“I am thrilled to join the DKMS team at such an exciting time in the organisation’s history. Together with my UK and international colleagues, and the vital support of our patients, donors, supporters and partners, I look forward to extending the impact our work in the UK and taking the organisation further towards our vision of providing a matching blood stem cell donor for everyone who needs one.”